SE-HMDS Laboratory for Molecular Haemato-Oncology at King's College Hospital

Laboratory overview

The Laboratory for Molecular Haemato-Oncology (LMH) is located at King’s College Hospital and is involved in the identification and quantification of molecular abnormalities/markers for diagnostic, prognostic and monitoring purposes in haematological malignancies. The department provides a wide repertoire of molecular diagnostic investigation for haematological malignancies. LMH is part of a comprehensive haematological malignancy diagnostic service (SE-HMDS) which provides services to the South East GLH

LMH is open from Monday to Friday: 9 am to 5:30 pm. The laboratory is not open on bank holidays.

LMH has been a UKAS accredited medical laboratory ( No. 9597) since May 2018. See the UKAS website for our Schedule of Accreditation 

Key features:

The laboratory is dedicated to providing an excellent service with emphasis on quality, speed, assay development and integration of new technologies and discoveries to ensure that we are aligned to the NHSE Genomics Test Directory

Genetic testing is provided by DNA sequencing (Next Generation), fragment analysis, quantitative PCR and SNP karyotyping.

LMH participates in accredited EQA schemes covering all of its core activities details on request

Our current test Request Forms can be seen on the SE Genomics website https://southeastgenomics.nhs.uk/glh/cancer-tests/haemato-oncology/

Our User Handbook and Cytogenomic Testing Processes can be seen below